| Cardiac Imaging and Diagnostics | Lifetime | 80 | GB 7 | 99.84 |
| Acute Myocardial Infarction Research | Lifetime | 173 | GB 10 | 99.44 |
| Apelin-related biomedical research | Lifetime | 33 | GB 5 | 98.33 |
| Coronary Interventions and Diagnostics | Lifetime | 200 | GB 10 | 99.32 |
| Cardiac Valve Diseases and Treatments | Lifetime | 329 | GB 14 | 99.30 |
| Advanced X-ray and CT Imaging | Lifetime | 255 | GB 7 | 98.50 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 58 | GB 8 | 97.93 |
| Climate Change and Health Impacts | Lifetime | 226 | GB 26 | 98.22 |
| Cardiovascular Disease and Adiposity | Lifetime | 277 | GB 25 | 98.51 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 334 | GB 8 | 98.63 |
| Air Quality and Health Impacts | Lifetime | 649 | GB 50 | 98.53 |
| Aortic Thrombus and Embolism | Lifetime | 22 | GB 1 | 96.91 |
| Heart Rate Variability and Autonomic Control | Lifetime | 643 | GB 52 | 98.00 |
| Protease and Inhibitor Mechanisms | Lifetime | 359 | GB 29 | 97.66 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 339 | GB 31 | 97.75 |
| Aortic aneurysm repair treatments | Lifetime | 455 | GB 34 | 97.52 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 905 | GB 57 | 97.82 |
| Cardiovascular Health and Disease Prevention | Lifetime | 732 | GB 61 | 96.91 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 858 | GB 55 | 96.50 |
| Air Quality Monitoring and Forecasting | Lifetime | 756 | GB 41 | 96.14 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 654 | GB 47 | 94.57 |
| Pericarditis and Cardiac Tamponade | Lifetime | 455 | GB 25 | 90.48 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 270 | GB 12 | 89.60 |
| Abdominal vascular conditions and treatments | Lifetime | 904 | GB 37 | 87.71 |
| COVID-19 impact on air quality | Lifetime | 520 | GB 33 | 76.78 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 12 | GB 4 | 99.82 |
| Acute Myocardial Infarction Research | 2021-2025 | 40 | GB 8 | 99.17 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 36 | GB 6 | 97.57 |
| Coronary Interventions and Diagnostics | 2021-2025 | 60 | GB 8 | 99.01 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 481 | GB 15 | 96.82 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 448 | GB 14 | 94.27 |
| Apelin-related biomedical research | 2021-2025 | 59 | GB 8 | 82.69 |
| Aortic Thrombus and Embolism | 2021-2025 | 20 | GB 2 | 82.20 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 947 | GB 38 | 87.08 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 78 | GB 7 | 82.12 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 160 | GB 13 | 75.45 |
| Cardiac tumors and thrombi | 2021-2025 | 767 | GB 26 | 70.29 |
| Nuclear Receptors and Signaling | 2021-2025 | 844 | GB 40 | 49.32 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 994 | GB 29 | 43.35 |